Failure to check the reliability of Certificate of Analysis (COA) at Regular Intervals.
Inspection Record
FinVector Oy — FDA 483 Findings
Inspectors Gene D Arcy · Lewis K AntwiThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Establishment of the reliability of the container and closure supplier's report of analyses is deficient in that the test results are not appropriately validated at appropriate intervals.
Written procedures for cleaning and maintenance fail to include maintenance and cleaning schedules.
Your firm has not adequately validated your adherent (b) (4) regarding cell infection in that certain combinations of critical parameters have not been assessed.
The quality control unit lacks responsibility to approve all procedures or specifications impacting on the identity, strength, quality and purity of drug products.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.